Booz Allen Hamilton (NYSE:BAH – Get Free Report) had its price target hoisted by analysts at BNP Paribas Exane from $70.00 to $85.00 in a report issued on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the business services provider’s stock. BNP Paribas Exane‘s price target suggests a potential upside of 1.03% […]